Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

about

CREB, NF-Y and MEIS1 conserved binding sites are essential to balance Myostatin promoter/enhancer activity during early myogenesis.

P2860

Q47629413-17CF1DC1-C1B7-44E1-9A7E-4585E0EA971B

P2860

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

Item

http://www.wikidata.org/entity/Q42268979

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@en

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@nl

type

Item

label

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@en

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@nl

prefLabel

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@en

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@nl

P1476

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

@en

P2093

A A S Carvalho

http://www.w3.org/2001/XMLSchema#string

A Santomauro

http://www.w3.org/2001/XMLSchema#string

D Feder

http://www.w3.org/2001/XMLSchema#string

F L A Fonseca

http://www.w3.org/2001/XMLSchema#string

L G Ferreira

http://www.w3.org/2001/XMLSchema#string

L P Oliveira

http://www.w3.org/2001/XMLSchema#string

M H Carvalho

http://www.w3.org/2001/XMLSchema#string

M Rugollini

http://www.w3.org/2001/XMLSchema#string

M T Nunes

http://www.w3.org/2001/XMLSchema#string

P O Delgado

http://www.w3.org/2001/XMLSchema#string

P2860

Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

Population frequencies of inherited neuromuscular diseases--a world survey

The erythropoietin receptor and its expression in tumor cells and other tissues

Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.

Cardiovascular effects of erythropoietin and anemia correction.

Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice.

EPO's alter ego: erythropoietin has multiple actions.

Exercise-induced vascular remodeling.

P304

966-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1414-431X20143858

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265610272

http://www.w3.org/2001/XMLSchema#string

P698

25296358

http://www.w3.org/2001/XMLSchema#string

P921

Erythropoietin

P932

4230286

http://www.w3.org/2001/XMLSchema#string

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

about

P2860

P2860

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932